Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine
Mantle cell lymphoma is a clinically heterogeneous disease occurring within a heterogeneous patient population, highlighting a need for personalized therapy to ensure optimal outcomes. It is therefore critical to understand the benefits and risks associated with both intensive and deintensified appr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Hematology/Oncology and Stem Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1658387617300328 |
id |
doaj-4e2756f5ac8546f395a69bbb69aed33b |
---|---|
record_format |
Article |
spelling |
doaj-4e2756f5ac8546f395a69bbb69aed33b2020-11-25T00:20:48ZengElsevierHematology/Oncology and Stem Cell Therapy1658-38762017-09-0110399115Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized MedicineJose D. Sandoval-Sus0Eduardo M. Sotomayor1Bijal D. Shah2Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Corresponding author at: H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.Department of Hematology/Oncology, George Washington University, Washington, D.C., USADepartment of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USAMantle cell lymphoma is a clinically heterogeneous disease occurring within a heterogeneous patient population, highlighting a need for personalized therapy to ensure optimal outcomes. It is therefore critical to understand the benefits and risks associated with both intensive and deintensified approaches. In the following review we provide a therapeutic roadmap to strategically guide treatment for newly diagnosed and relapsed/refractory patients highlighting pivotal and recently published results involving known and novel therapies. Keywords: Mantle cell lymphoma, Prognosis, Treatmenthttp://www.sciencedirect.com/science/article/pii/S1658387617300328 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jose D. Sandoval-Sus Eduardo M. Sotomayor Bijal D. Shah |
spellingShingle |
Jose D. Sandoval-Sus Eduardo M. Sotomayor Bijal D. Shah Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine Hematology/Oncology and Stem Cell Therapy |
author_facet |
Jose D. Sandoval-Sus Eduardo M. Sotomayor Bijal D. Shah |
author_sort |
Jose D. Sandoval-Sus |
title |
Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine |
title_short |
Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine |
title_full |
Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine |
title_fullStr |
Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine |
title_full_unstemmed |
Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine |
title_sort |
mantle cell lymphoma: contemporary diagnostic and treatment perspectives in the age of personalized medicine |
publisher |
Elsevier |
series |
Hematology/Oncology and Stem Cell Therapy |
issn |
1658-3876 |
publishDate |
2017-09-01 |
description |
Mantle cell lymphoma is a clinically heterogeneous disease occurring within a heterogeneous patient population, highlighting a need for personalized therapy to ensure optimal outcomes. It is therefore critical to understand the benefits and risks associated with both intensive and deintensified approaches. In the following review we provide a therapeutic roadmap to strategically guide treatment for newly diagnosed and relapsed/refractory patients highlighting pivotal and recently published results involving known and novel therapies. Keywords: Mantle cell lymphoma, Prognosis, Treatment |
url |
http://www.sciencedirect.com/science/article/pii/S1658387617300328 |
work_keys_str_mv |
AT josedsandovalsus mantlecelllymphomacontemporarydiagnosticandtreatmentperspectivesintheageofpersonalizedmedicine AT eduardomsotomayor mantlecelllymphomacontemporarydiagnosticandtreatmentperspectivesintheageofpersonalizedmedicine AT bijaldshah mantlecelllymphomacontemporarydiagnosticandtreatmentperspectivesintheageofpersonalizedmedicine |
_version_ |
1725365794542452736 |